MedicaidBilling CodesMedium impact
May 2026 TMPPM Update for Colony Stimulating Factors
Texas Medicaid·TX · Oncology, Hematology·General
Effective date
May 1, 2026
We identified it
Apr 13, 2026
Summary
Texas Medicaid will add filgrastim-txid (Nypozi) with procedure code Q5148 to their covered colony stimulating factors effective May 1, 2026. This biosimilar drug will be covered alongside existing filgrastim and pegfilgrastim options.
Action Required
By May 1, 2026: Billing team must update billing system to include new HCPCS code Q5148 for filgrastim-txid (Nypozi) biosimilar. Add code to drug formulary lists and ensure claims processing system recognizes the new code for Texas Medicaid patients. Contact individual MCOs for specific administrative requirements.